Licensing Opportunities
(Currently Available)
Classified by Targets
High-priority targets currently sought after by MNCs and biotech companies. If you're interested in licensing opportunities, we’d be happy to connect.
T1) ROR1
T2) CXCR3
T3) VAV1
T4) ActRII
T5) KRAS G12D
T6) Pan Ras
T7) 4-1BB
T8) OX40
T9) CRAF
T10) EZH2
T11) Gspt1
T12) TNFR
T13) IL4Ra
T14) IL31
T15) PI3K
T16) RTK
T17) Bcl-2
T18) Kif18A
T19) CD40
T20) CNTN4
****************************************************************
Classified By Modalities
Current top-priority therapeutic modalities in demand. If you're interested in licensing opportunities, we’d be happy to connect.
M1) ADC
M2) Protein Degrader
M3) Ab
M4) BsAb, TriAb
M5) NanoAb
M6) Small RNAs
M7) Gene editing
M8) Gene Therapy
M9) Cell therapy
M10) Oncolytic Virus
M11) Nanoparticles
M12) PDC
M13) SMDC
M14) Polymer
M15) Stem cells
M16) Small Molecule
Any Questions or Inquiries, Please Feel Free to Reach Out